Sage Therapeutics Inc. (SAGE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sage Therapeutics Inc.

    NASDAQ: SAGE · Real-Time Price · USD
    8.68
    0.00 (0.00%)
    At close: Jul 30, 2025, 3:59 PM

    Sage Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 81.02M 70.99M 162.7M 294.23M
    Short-Term Investments
    		 423.4M 682.19M 1.11B 1.45B
    Long-Term Investments
    		 n/a n/a 1.27M 1.27M
    Other Long-Term Assets
    		 4.28M 6.55M 69.26M 4.25M
    Receivables
    		 9.13M 83.01M 13.66M 18.51M
    Inventory
    		 n/a n/a -64.49M -18.51M
    Other Current Assets
    		 17.75M 33.16M 50.83M n/a
    Total Current Assets
    		 531.3M 869.35M 1.27B 1.8B
    Property-Plant & Equipment
    		 11.64M 6.38M 13.43M 19.13M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 15.92M 12.93M 83.95M 24.64M
    Total Assets
    		 547.22M 882.28M 1.36B 1.83B
    Account Payables
    		 12.7M 10.32M 18.95M 10.45M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 7.64M 7.47M
    Other Current Liabilities
    		 14.84M 21.34M 35.65M 41.19M
    Total Current Liabilities
    		 71.61M 82.75M 99.26M 85.19M
    Long-Term Debt
    		 n/a n/a 4.49M 10.96M
    Other Long-Term Liabilities
    		 n/a n/a -4.39M -10.86M
    Total Long-Term Liabilities
    		 10.52M n/a 4.59M 11.06M
    Total Liabilities
    		 82.13M 82.75M 103.85M 96.26M
    Total Debt
    		 11.84M 5.17M 12.13M 18.43M
    Book Value
    		 465.09M 799.53M 1.25B 1.73B
    Book Value Per Share
    		 7.65 13.36 21.12 29.47
    Common Stock
    		 6K 6K 6K 6K
    Retained Earnings
    		 -2.97B -2.57B -2.03B -1.5B
    Comprehensive Income
    		 244K -814K -10.21M -2.66M
    Shareholders Equity
    		 465.09M 799.53M 1.25B 1.73B
    Total Investments
    		 423.4M 682.19M 1.11B 1.45B

    Add to Watchlist